Alphabet announces plans to nearly double capital expenditures this year, betting big on AI infrastructure as its cloud division outpaces rivals and drives revenue growth.
A sustained slide in Wolters Kluwer's share price has investors questioning whether the market has overcorrected, creating a potential entry point, or if challenges in its legacy businesses and rising AI competition justify the pessimism.
A year after the implementation of sweeping tariffs on imports, small business owners in the Fayetteville area describe a sustained squeeze on profits, with some dipping into personal savings to stay afloat amidst rising costs and complex supply chains.
The Swedish telecom giant's robust 2025 earnings and increased dividend proposal have investors reassessing its stock. Despite a dip in sales, net income soared, raising questions about whether its current share price fully reflects its growth trajectory in an AI-driven network landscape.
Final assays from Titan Minerals' resource drilling at its Dynasty Gold Project in Ecuador have significantly extended high-grade mineralization at depth, promising a substantial boost to the project's resource base ahead of a key update scheduled for early 2026.
Florida drivers are facing another week of rising fuel costs, with the state average increasing for a second consecutive week. While prices remain below the national average, the upward trend is squeezing household budgets.
A deep-dive valuation analysis suggests Cochlear Limited's current market price may be stretched. Using a discounted cash flow model, we find a significant gap between the calculated fair value and the trading price, raising questions for investors.
After 26 years, Cisco Systems stock has finally surpassed its internet bubble peak, driven by enterprise network upgrades and surging demand for AI-ready infrastructure. Analysts see a multi-year growth runway ahead.
Two key surveys confirm the U.S. services industry maintained its growth momentum last month, fueled by rising employment and business activity. However, persistent price pressures and a dip in foreign demand signal ongoing economic headwinds that could delay interest rate cuts.
CNBC's Jim Cramer offered a nuanced assessment of Marvell Technology, praising its execution but labeling it a 'derivative' company in the competitive semiconductor landscape, sparking debate among investors.
The Department of Homeland Security is scrambling to contain a mounting constitutional crisis after six of its former top lawyers jointly condemned ICE's controversial practice of using administrative warrants to enter private homes—a move legal experts say flouts Fourth Amendment protections.
The 106-year-old outdoor apparel brand Eddie Bauer is reportedly preparing for a Chapter 11 bankruptcy filing, a move that could shutter its entire North American store fleet. This would mark the third major financial crisis for the heritage brand in two decades.
Ciena (CIEN) is drawing renewed investor scrutiny following significant contract wins with Telekom Srbija and Trans Pacific Networks, coupled with anticipated showcases at the upcoming Mobile World Congress. This comes as the stock rides a wave of strong momentum, raising critical questions about whether its current price fully reflects future growth prospects in the high-capacity networking arena.
Following a sharp post-earnings sell-off, Axon Enterprise (AXON) faces questions about its premium valuation. Yet, management's long-term vision and the company's unique market position have some investors seeing a potential entry point.
Secretary of State Marco Rubio confirmed Iran's request to relocate planned nuclear discussions from Turkey, as diplomatic maneuvering intensifies ahead of a potential Friday meeting. Rubio outlined key U.S. prerequisites for substantive dialogue amid regional tensions.
Following CSX Corporation's Q4 earnings, major Wall Street firms have recalibrated their price targets. While near-term challenges are acknowledged, the long-term outlook for the railroad giant hinges on margin recovery and a demand rebound.
Major automakers have expressed support for the Trump administration's proposal to significantly relax future fuel efficiency targets, while urging adjustments to specific provisions on credit trading and vehicle classifications.
Pfizer's promising mid-stage trial results for its monthly injectable obesity drug, Metsera, signal a credible new competitor for market leaders Novo Nordisk and Eli Lilly, prompting analysts to flag intensifying rivalry in the lucrative weight-loss therapeutics sector.
Despite a recent 5% slide in its share price, Dorman Products (DORM) boasts a robust Return on Equity and a history of solid earnings growth, raising questions about whether the market is overlooking its financial strength.
The landmark $100 billion infrastructure partnership between OpenAI and Nvidia has failed to materialize into a binding agreement, exposing underlying tensions over chip supply and performance demands, and raising broader concerns about speculative dynamics in the AI sector.
